JCR PHARMACEUTICALS CO., LTD. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 797 JPY | +0,50% |
|
+2,05% | -32,00% |
Totale waarde
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 200.747 | 290.393 | 443.148 | 279.312 | 176.306 | 99.467 | - | - |
| Bedrijfswaarde 1 | 197.730 | 287.957 | 434.988 | 266.435 | 185.828 | 112.126 | 108.463 | 106.517 |
| K/w-verhouding | 54 x | 108 x | 64,2 x | 19,2 x | 46,6 x | 13,7 x | 15,8 x | 16,1 x |
| Dividendrendement | 0,46% | 0,34% | 0,33% | 0,89% | 1,42% | 2,46% | 2,51% | 2,56% |
| Marktkapitalisatie/omzet | 8,67 x | 11,7 x | 14,7 x | 5,47 x | 5,13 x | 2,19 x | 2,38 x | 2,38 x |
| Bedrijfswaarde/omzet | 8,54 x | 11,6 x | 14,5 x | 5,22 x | 5,41 x | 2,47 x | 2,6 x | 2,55 x |
| Bedrijfswaarde/EBITDA | 31,3 x | 61,6 x | 42,8 x | 12,2 x | 26,7 x | 9,02 x | 10,3 x | 10,2 x |
| Bedrijfswaarde/FCF | 62,2 x | 3.235 x | 61,7 x | 44,1 x | -9,06 x | -98,4 x | 9,25 x | 16,3 x |
| FCF Yield | 1,61% | 0,03% | 1,62% | 2,27% | -11% | -1,02% | 10,8% | 6,15% |
| Price to Book | 6,64 x | 9,13 x | 11,7 x | 5,55 x | 3,43 x | 1,73 x | 1,6 x | 1,49 x |
| Aantal aandelen (in duizenden) | 123.158 | 123.309 | 123.612 | 123.754 | 124.774 | 124.801 | - | - |
| Referentieprijs 2 | 1.630 | 2.355 | 3.585 | 2.257 | 1.413 | 797,0 | 797,0 | 797,0 |
| Datum van publicatie | 10-05-19 | 12-05-20 | 13-05-21 | 12-05-22 | 11-05-23 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 23.160 | 24.781 | 30.085 | 51.082 | 34.343 | 45.366 | 41.747 | 41.771 |
| EBITDA 1 | 6.310 | 4.678 | 10.161 | 21.878 | 6.972 | 12.432 | 10.568 | 10.418 |
| Bedrijfsresultaat (EBIT) 1 | 4.967 | 3.244 | 8.269 | 19.933 | 4.975 | 10.386 | 8.613 | 8.398 |
| Operationele Marge | 21,45% | 13,09% | 27,49% | 39,02% | 14,49% | 22,89% | 20,63% | 20,1% |
| Resultaat voor belastingen (EBT) 1 | 4.928 | 3.422 | 8.653 | 19.404 | 5.412 | 9.900 | 8.113 | 7.720 |
| Nettowinst (verlies) 1 | 3.715 | 2.678 | 6.892 | 14.507 | 3.772 | 7.245 | 6.283 | 6.153 |
| Nettomarge | 16,04% | 10,81% | 22,91% | 28,4% | 10,98% | 15,97% | 15,05% | 14,73% |
| WPA 2 | 30,17 | 21,72 | 55,81 | 117,3 | 30,35 | 58,15 | 50,40 | 49,36 |
| Free Cash Flow 1 | 3.177 | 89 | 7.051 | 6.039 | -20.502 | -1.139 | 11.723 | 6.553 |
| FCF-marge | 13,72% | 0,36% | 23,44% | 11,82% | -59,7% | -2,51% | 28,08% | 15,69% |
| Kasstroomconversie (ebitda) | 50,35% | 1,9% | 69,39% | 27,6% | - | - | 110,93% | 62,9% |
| Kasstroomconversie (nettowinst) | 85,52% | 3,32% | 102,31% | 41,63% | - | - | 186,58% | 106,5% |
| Dividend per aandeel 2 | 7,500 | 8,000 | 12,00 | 20,00 | 20,00 | 19,57 | 20,00 | 20,43 |
| Datum van publicatie | 10-05-19 | 12-05-20 | 13-05-21 | 12-05-22 | 11-05-23 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: Maart | 2020 S1 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 11.236 | 10.951 | 19.134 | 28.383 | 11.887 | 10.812 | 22.699 | 9.606 | 5.975 | 15.581 | 11.115 | 7.647 | 18.762 | 10.808 | 13.464 | 24.272 | 9.446 | 12.382 | 22.628 | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | 998 | 1.307 | 6.962 | 13.640 | 4.716 | 1.577 | 6.293 | 1.536 | -792 | 744 | 4.209 | 22 | 4.231 | 2.066 | 4.832 | 6.898 | 911 | 3.066 | 4.252 | - | - | - | - |
| Operationele Marge | 8,88% | 11,93% | 36,39% | 48,06% | 39,67% | 14,59% | 27,72% | 15,99% | -13,26% | 4,78% | 37,87% | 0,29% | 22,55% | 19,12% | 35,89% | 28,42% | 9,64% | 24,76% | 18,79% | - | - | - | - |
| Resultaat voor belastingen (EBT) 1 | 1.098 | 1.381 | 7.272 | 12.729 | 4.993 | 1.682 | 6.675 | 2.083 | - | 1.560 | 3.720 | 132 | 3.852 | 2.260 | - | 7.120 | 251 | 3.162 | 3.413 | - | - | - | - |
| Nettowinst (verlies) 1 | 922 | 1.227 | 5.665 | 9.234 | 3.687 | 1.586 | 5.273 | 1.368 | -406 | 962 | 2.606 | 204 | 2.810 | 1.610 | 3.643 | 5.253 | -93 | 2.380 | 2.627 | - | - | - | - |
| Nettomarge | 8,21% | 11,2% | 29,61% | 32,53% | 31,02% | 14,67% | 23,23% | 14,24% | -6,79% | 6,17% | 23,45% | 2,67% | 14,98% | 14,9% | 27,06% | 21,64% | -0,98% | 19,22% | 11,61% | - | - | - | - |
| WPA 2 | 7,488 | 9,940 | 45,87 | 74,66 | 29,79 | 12,81 | 42,60 | 11,06 | -3,290 | 7,770 | 20,96 | 1,620 | 22,58 | 12,91 | 29,19 | 42,10 | -0,7500 | 16,69 | - | - | - | - | - |
| Dividend per aandeel 2 | 3,750 | 4,500 | - | 10,00 | - | - | - | - | - | 10,00 | - | - | - | - | - | 10,00 | - | 10,00 | - | 10,00 | - | 10,00 | - |
| Datum van publicatie | 31-10-19 | 26-10-20 | 13-05-21 | 28-10-21 | 27-01-22 | 12-05-22 | 12-05-22 | 27-07-22 | 26-10-22 | 26-10-22 | 31-01-23 | 11-05-23 | 11-05-23 | 26-07-23 | 25-10-23 | 25-10-23 | 26-01-24 | - | - | - | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Balans
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | - | - | - | 9.522 | 12.659 | 8.996 | 7.051 |
| Nettokaspositie 1 | 3.017 | 2.436 | 8.160 | 12.877 | - | - | - | - |
| Hefboom (schuld/ebitda) | - | - | - | - | 1,366 x | 1,018 x | 0,8513 x | 0,6768 x |
| Free Cash Flow 1 | 3.177 | 89 | 7.051 | 6.039 | -20.502 | -1.139 | 11.723 | 6.553 |
| ROE (netto-inkomsten/eigen vermogen) | 13% | 8,6% | 19,5% | 32,9% | 7,4% | 13,3% | 10,6% | 9,65% |
| ROA (netto-inkomsten/totale activa) | 12,5% | 7,29% | 14,2% | 24% | 5,64% | 7,63% | 3,8% | 3,55% |
| Totale activa 1 | 29.656 | 36.714 | 48.585 | 60.440 | 66.860 | 94.915 | 165.346 | 173.328 |
| Nettoactief per aandeel 2 | 246,0 | 258,0 | 306,0 | 407,0 | 412,0 | 460,0 | 497,0 | 535,0 |
| Cashflow per aandeel 2 | 41,10 | 33,40 | 71,10 | 133,0 | 46,40 | 67,90 | 60,40 | 59,90 |
| Capex 1 | 728 | 4.838 | 4.780 | 11.333 | 8.023 | 5.250 | 5.375 | 2.750 |
| Capex/omzet | 3,14% | 19,52% | 15,89% | 22,19% | 23,36% | 11,57% | 12,88% | 6,58% |
| Datum van publicatie | 10-05-19 | 12-05-20 | 13-05-21 | 12-05-22 | 11-05-23 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
Verkoop
Koop
Gemiddeld advies
Accumuleren
Aantal analisten
7
Laatste slotkoers
797
JPY
Gemiddelde koersdoel
1.557
JPY
Spread / Gemiddelde doel
+95,38%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -32,00% | 632 mln. | |
| +25,83% | 661 mld. | |
| +27,00% | 566 mld. | |
| -6,76% | 352 mld. | |
| +20,34% | 332 mld. | |
| +3,00% | 283 mld. | |
| +13,09% | 231 mld. | |
| +5,46% | 200 mld. | |
| -9,61% | 195 mld. | |
| -6,26% | 145 mld. |
- Beurs
- Aandelen
- Koers 4552
- Financiën JCR Pharmaceuticals Co., Ltd.
